News & Alerts
-
Oct- 2023 -17 October
Zealand Pharma’s Amylin Analog ZP8396 Shows Promise for Overcoming Obesity Challenges
Zealand Pharma, a biotechnology company, presented data for their amylin analog ZP8396 at the Obesity Society Annual Meeting (ObesityWeek) in…
Read More » -
17 October
Tessellate BIO Emerges from Stealth with €8 Million in Seed Funding, Pioneering Novel Synthetic Lethality Approaches in Oncology
Tessellate BIO, a preclinical stage biotechnology company specializing in innovative Synthetic Lethality approaches, made its official debut from stealth today…
Read More » -
17 October
Anticoagulant Reversal Drugs Market Projected to Exceed USD 2.3 Billion by 2031
Transparency Market Research, a prominent market research firm, has recently published an exclusive report projecting significant growth in the Anticoagulant…
Read More » -
16 October
Bayer Launches Pioneering QR Code Packaging for Visually Impaired Consumers in the UK
Bayer Pharmaceutical has introduced an innovative and accessible packaging update for one of its over-the-counter (OTC) products in the UK.…
Read More » -
16 October
Killer Indonesian Cough Syrup Contained Alarmingly High Levels Of Toxins – Court Documents
An Indonesian drugmaker, Afi Farma, is facing serious allegations after its cough syrup was linked to the tragic deaths of…
Read More » -
16 October
Pharmacovigilance & Drug Safety Software Market to Hit $312 Million by 2030
Researchers have unveiled a comprehensive report that delves deep into the Pharmacovigilance and Drug Safety Software Market. This extensive analysis…
Read More » -
16 October
Somatostatin Analogs Market Expected to Reach $10 Billion by 2035, New Research Reveals
The global somatostatin analogs market is poised for significant expansion, with a projected Compound Annual Growth Rate (CAGR) of approximately…
Read More » -
16 October
WebMD Symptom Checker: Accuracy, How to Use It, Benefits, Limitations
The internet and advancements in technology have revolutionized the way we access health information, and WebMD, one of the most…
Read More » -
11 October
FDA Warns Patients and Health Care Providers About Potential Risks Associated With Compounded Ketamine Products
Audience: Patients, Health Care Providers There is increased interest in compounded ketamine products (including oral formulations) for the treatment of…
Read More » -
11 October
Misinformation Surrounds FDA Proposal on Salt Substitutes
A recent proposal by the U.S. Food and Drug Administration (FDA) to allow the use of salt substitutes in standardized…
Read More »